Regeneron Pharmaceuticals, a biotechnology company with a long history of large-scale genetics research, plans to buy DNA testing firm 23andMe out of bankruptcy, announcing Monday it was named the ...

(Reuters) -Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy ...

Genetic testing company 23andMe never hit on a sustainable business model and went bankrupt. Now, it's being sold to a non-profit launched by the co-founder, delaying addressing data privacy concerns.

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...

Every major app promised privacy at the beginning. No ads. No data selling. No tracking. But as billions of dollars entered ...

Genetic testing firm 23andMe has been fined £2.31 million by the UK’s data protection watchdog for “serious security failings” after personal information of more than 155,000 UK users was accessed in ...

A bankruptcy judge has approved the sale of the insolvent genetics firm 23andMe to a nonprofit run by one of the company's co-founders. The deal effectively avoids the controversial transfer of DNA ...

Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...

Add Yahoo as a preferred source to see more of our stories on Google. Hackers used a credential stuffing attack to gain access to 23andMe accounts in October 2023. Ever used 23andMe? If you have, you ...

23andMe, a pioneer in the DNA testing kit industry, announced that it has filed for Chapter 11 bankruptcy protection and recently asked to select an independent customer data representative regarding ...

23andMe was once a high-flying biotech firm. It collected a trove of DNA data on millions of its customers, and then it went bust. The fate of that data has been at the center of a legal battle over ...

Today is the deadline for customers of the genetic testing company 23andMe to file a claim as part of a restructuring in its bankruptcy case. In filing a claim, eligible customers can seek ...